Freestone Capital Holdings’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,796
| Closed | -$266K | – | 398 |
|
|
2022
Q2 | $266K | Sell |
2,796
-3,182
| -53% | -$303K | 0.01% | 348 |
|
|
2022
Q1 | $704K | Buy |
5,978
+996
| +20% | +$117K | 0.03% | 290 |
|
|
2021
Q4 | $645K | Buy |
4,982
+996
| +25% | +$129K | 0.03% | 281 |
|
|
2021
Q3 | $451K | Buy |
3,986
+892
| +29% | +$101K | 0.02% | 295 |
|
|
2021
Q2 | $320K | Buy |
3,094
+172
| +6% | +$17.8K | 0.02% | 329 |
|
|
2021
Q1 | $244K | Buy |
2,922
+856
| +41% | +$71.5K | 0.01% | 355 |
|
|
2020
Q4 | $188K | Buy |
2,066
+544
| +36% | +$49.6K | 0.01% | 354 |
|
|
2020
Q3 | $121K | Buy |
+1,522
| New | +$121K | 0.01% | 376 |
|